Jushi Holdings Inc. (JUSH.CN)
CAD 0.56
(3.7%)
CAD 0.56
(3.7%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 40.96 Million USD | 226.48% |
| 2022 | -121.65 Million USD | -217.19% |
| 2021 | 111.25 Million USD | -53.44% |
| 2020 | -237.3 Million USD | 70.98% |
| 2019 | -27.57 Million CAD | 0.0% |
| 2017 | -142.51 Thousand CAD | -34.45% |
| 2016 | -95.81 Thousand USD | 97.17% |
| 2015 | -5.07 Million USD | -296.06% |
| 2014 | -1.14 Million CAD | 36.96% |
| 2013 | -1.61 Million CAD | 0.28% |
| 2012 | -1.55 Million CAD | 54.64% |
| 2011 | -3.26 Million CAD | -65.79% |
| 2010 | -1.93 Million CAD | -7360.55% |
| 2009 | -611.18 Thousand CAD | 27.89% |
| 2008 | -37.12 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 16.27 Million USD | 53.2% |
| 2024 Q1 | 12.97 Million USD | 138.92% |
| 2023 FY | - USD | 226.48% |
| 2023 Q3 | 10.04 Million USD | 1.99% |
| 2023 Q2 | 9.84 Million USD | 77.9% |
| 2023 Q1 | 5.53 Million USD | 187.62% |
| 2023 Q4 | 11.72 Million USD | 16.74% |
| 2022 Q4 | -6.31 Million USD | -24.15% |
| 2022 Q2 | -7.81 Million USD | -52.31% |
| 2022 Q1 | -5.13 Million USD | 59.1% |
| 2022 FY | - USD | -217.19% |
| 2022 Q3 | -5.08 Million USD | 34.92% |
| 2021 Q2 | -991 Thousand USD | -439.38% |
| 2021 Q1 | 292 Thousand USD | -82.98% |
| 2021 Q4 | -12.54 Million USD | -612.2% |
| 2021 Q3 | 2.45 Million USD | 347.23% |
| 2021 FY | - USD | -53.44% |
| 2020 FY | - USD | 70.98% |
| 2020 Q1 | -6.64 Million USD | 6.44% |
| 2020 Q2 | -2.19 Million USD | 67.01% |
| 2020 Q3 | 19 Thousand USD | 100.87% |
| 2020 Q4 | 1.71 Million USD | 8931.58% |
| 2019 Q3 | -2.82 Million CAD | 75.06% |
| 2019 Q2 | -11.31 Million CAD | -98.93% |
| 2019 Q4 | -7.1 Million CAD | -151.67% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q1 | -5.68 Million CAD | -27832.51% |
| 2018 Q3 | -24.56 Thousand CAD | -28.23% |
| 2018 Q2 | -19.16 Thousand CAD | 82.9% |
| 2018 Q1 | -112.05 Thousand USD | -673.96% |
| 2018 Q4 | -20.36 Thousand CAD | 17.12% |
| 2017 FY | - CAD | -34.45% |
| 2017 Q2 | 953.84 USD | 104.41% |
| 2017 Q3 | 14.03 Thousand USD | 1370.99% |
| 2017 Q1 | -21.62 Thousand USD | -32.57% |
| 2017 Q4 | -14.47 Thousand USD | -203.19% |
| 2016 Q2 | -16.61 Thousand USD | 99.51% |
| 2016 Q1 | -3.39 Million USD | -7824.4% |
| 2016 Q3 | -19.05 Thousand USD | -14.68% |
| 2016 Q4 | -16.31 Thousand USD | 14.37% |
| 2016 FY | - USD | 97.17% |
| 2015 Q3 | -94.64 Thousand CAD | 48.71% |
| 2015 FY | - USD | -296.06% |
| 2015 Q4 | -42.86 Thousand CAD | 54.71% |
| 2015 Q2 | -184.54 Thousand CAD | -41.35% |
| 2015 Q1 | -130.56 Thousand CAD | 65.11% |
| 2014 Q4 | -374.18 Thousand CAD | -64.52% |
| 2014 FY | - CAD | 36.96% |
| 2014 Q1 | -576.59 Thousand CAD | -70.41% |
| 2014 Q2 | -236.08 Thousand CAD | 59.06% |
| 2014 Q3 | -227.43 Thousand CAD | 3.66% |
| 2013 Q4 | -338.35 Thousand CAD | -0.57% |
| 2013 FY | - CAD | 0.28% |
| 2013 Q1 | -223.14 Thousand CAD | 53.71% |
| 2013 Q2 | -256.49 Thousand CAD | -14.95% |
| 2013 Q3 | -336.44 Thousand CAD | -31.17% |
| 2012 Q1 | -752.89 Thousand CAD | -95.84% |
| 2012 Q2 | -276.77 Thousand CAD | 63.24% |
| 2012 FY | - CAD | 54.64% |
| 2012 Q3 | -509.9 Thousand CAD | -84.23% |
| 2012 Q4 | -482.05 Thousand CAD | 5.46% |
| 2011 Q3 | -275.73 Thousand CAD | 86.61% |
| 2011 Q1 | -651 Thousand CAD | -14.39% |
| 2011 Q2 | -2.05 Million CAD | -216.21% |
| 2011 Q4 | -384.44 Thousand CAD | -39.43% |
| 2011 FY | - CAD | -65.79% |
| 2010 FY | - CAD | -7360.55% |
| 2010 Q4 | -569.11 Thousand CAD | -57.92% |
| 2010 Q3 | -360.39 Thousand CAD | -715.09% |
| 2010 Q1 | -15.45 Thousand CAD | -110.23% |
| 2010 Q2 | -44.21 Thousand CAD | -186.0% |
| 2009 Q2 | -3149.54 CAD | 70.02% |
| 2009 FY | - CAD | 27.89% |
| 2009 Q4 | -7353.84 CAD | -81.24% |
| 2009 Q3 | -4057.52 CAD | -28.83% |
| 2009 Q1 | -10.5 Thousand CAD | -44.03% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | -4219.98 CAD | 0.0% |
| 2008 Q4 | -7293.07 CAD | -123.98% |
| 2008 Q3 | -3256.14 CAD | 86.56% |
| 2008 Q2 | -24.23 Thousand CAD | -474.25% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 774.41% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 2137.395% |
| Blueberries Medical Corp. | -1.22 Million CAD | 3452.596% |
| The BC Bud Corporation | -1.19 Million CAD | 3524.847% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 731.675% |
| CordovaCann Corp. | -1.6 Million CAD | 2655.921% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 1661.365% |
| Captor Capital Corp. | 2.42 Million CAD | -1591.812% |
| City View Green Holdings Inc. | -2.01 Million CAD | 2133.38% |
| 1CM Inc. | 1.31 Million CAD | -3018.45% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 165314.593% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 1954.816% |
| IM Cannabis Corp. | -2.79 Million CAD | 1568.16% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 1030.463% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 10543.647% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 1382.858% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | -3488.088% |
| Ovation Science Inc. | -778.83 Thousand CAD | 5359.37% |
| Pharmadrug Inc. | -1.33 Million CAD | 3168.259% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 776.373% |
| RAMM Pharma Corp. | -6.3 Million CAD | 749.97% |
| RIV Capital Inc. | -20.28 Million CAD | 301.977% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 832.111% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 152.792% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 1488.193% |
| 1933 Industries Inc. | -10.03 Million CAD | 508.271% |
| Red Light Holland Corp. | -5.25 Million CAD | 879.353% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 5433.597% |
| Xebra Brands Ltd. | -1.49 Million CAD | 2839.917% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 3002.48% |